Movement Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 11-20 of 535 total displayed.

Past content

Corrections
Error in Table in: Progress and Challenges in RNA Interference Therapy for Huntington Disease

Arch Neurol 2009; 66: 1272. [Full text] [PDF]  

Original Contributions
Association of Ideomotor Apraxia With Frontal Gray Matter Volume Loss in Corticobasal Syndrome

Edward D. Huey; Matteo Pardini; Alyson Cavanagh; Eric M. Wassermann; Dimitrios Kapogiannis; Salvatore Spina; Bernardino Ghetti; Jordan Grafman
Arch Neurol 2009; 66: 1274-1280. [Abstract] [Full text] [PDF]  

Observations
Polymyoclonus, Laryngospasm, and Cerebellar Ataxia Associated With Adenocarcinoma and Multiple Neural Cation Channel Autoantibodies

Shen-Yang Lim; Warren P. Mason; Nathan P. Young; Robert Chen; James H. Bower; Andrew McKeon; Sean J. Pittock; Anthony E. Lang
Arch Neurol 2009; 66: 1285-1287. [Abstract] [Full text] [PDF] [ Video Supplement ]  

Original Contributions
Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience

Sotirios A. Parashos; Christopher J. Swearingen; Kevin M. Biglan; Ivan Bodis-Wollner; Grace S. Liang; G. Webster Ross; Barbara C. Tilley; Lisa M. Shulman; for the NET-PD Investigators
Arch Neurol 2009; 66: 1099-1104. [Abstract] [Full text] [PDF]  

Original Contributions
Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study

Caroline M. Tanner; G. Webster Ross; Sarah A. Jewell; Robert A. Hauser; Joseph Jankovic; Stewart A. Factor; Susan Bressman; Amanda Deligtisch; Connie Marras; Kelly E. Lyons; Grace S. Bhudhikanok; Diana F. Roucoux; Cheryl Meng; Robert D. Abbott; J. William Langston
Arch Neurol 2009; 66: 1106-1113. [Abstract] [Full text] [PDF]  

Original Contributions
Comparison of Risk Factor Profiles in Incidental Lewy Body Disease and Parkinson Disease

Roberta Frigerio; Hiroshige Fujishiro; Demetrius M. Maraganore; Kevin J. Klos; Anthony DelleDonne; Michael G. Heckman; Julia E. Crook; Keith A. Josephs; Joseph E. Parisi; Bradley F. Boeve; Dennis W. Dickson; J. Eric Ahlskog
Arch Neurol 2009; 66: 1114-1119. [Abstract] [Full text] [PDF]  

The World in Medicine
Huntington Disease Setback

Joan Stephenson
JAMA 2009; 302: 732-b. [Extract] [Full text] [PDF]  

Original Articles
Reduced 4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease

Philipp M. Meyer; Karl Strecker; Kai Kendziorra; Georg Becker; Swen Hesse; Dominique Woelpl; Anke Hensel; Marianne Patt; Dietlind Sorger; Florian Wegner; Donald Lobsien; Henryk Barthel; Peter Brust; Hermann J. Gertz; Osama Sabri; Johannes Schwarz
Arch Gen Psychiatry 2009; 66: 866-877. [Abstract] [Full text] [PDF] [ eFigures ]  

Neurological Reviews
Progress and Challenges in RNA Interference Therapy for Huntington Disease

Scott Q. Harper
Arch Neurol 2009; 66: 933-938. [Abstract] [Full text] [PDF]  

Original Contributions
Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience

Sotirios A. Parashos; Christopher J. Swearingen; Kevin M. Biglan; Ivan Bodis-Wollner; Grace S. Liang; G. Webster Ross; Barbara C. Tilley; Lisa M. Shulman; for the NET-PD Investigators
Arch Neurol 2009.159. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54